Nanjing 1718 Biotech Co. Ltd Report issue

Government

Organization Overview

First Clinical Trial
2017
NCT03103815
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

amino acids (Freamine) (1 trial)

multivitamins (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2